168 related articles for article (PubMed ID: 21119092)
21. Baclofen and γ-hydroxybutyrate (GHB), a dangerous combination.
Kamal RM; Qurishi R; De Jong CA
J Addict Med; 2015; 9(1):75-7. PubMed ID: 25494007
[TBL] [Abstract][Full Text] [Related]
22. [Baclofen for alcohol addiction].
Helland A; Bramness JG
Tidsskr Nor Laegeforen; 2011 Nov; 131(21):2132-3. PubMed ID: 22048211
[TBL] [Abstract][Full Text] [Related]
23. [Baclofen: when does one know the scientific truth about its effectiveness in alcoholic disease?].
Nau JY
Rev Med Suisse; 2015 Sep; 11(485):1674-5. PubMed ID: 26540999
[No Abstract] [Full Text] [Related]
24. Tolerability of High-dose Baclofen in the Treatment of Patients with Alcohol Disorders: A Retrospective Study.
Rigal L; Legay Hoang L; Alexandre-Dubroeucq C; Pinot J; Le Jeunne C; Jaury P
Alcohol Alcohol; 2015 Sep; 50(5):551-7. PubMed ID: 26037372
[TBL] [Abstract][Full Text] [Related]
25. Safety reports on the off-label use of baclofen for alcohol-dependence: recommendations to improve causality assessment.
Rolland B; Auffret M; Franchitto N
Expert Opin Drug Saf; 2016 Jun; 15(6):747-51. PubMed ID: 26987987
[TBL] [Abstract][Full Text] [Related]
26. [Baclofen and liver cirrhosis: literature review and safety precautions implemented within the system CAMTEA].
Rolland B; Deheul S; Louvet A; Gautier S; Cottencin O; Bordet R;
Therapie; 2014; 69(2):143-7. PubMed ID: 24926632
[TBL] [Abstract][Full Text] [Related]
27. Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocol.
Rolland B; Auffret M; Labreuche J; Lapeyre-Mestre M; Dib M; Kemkem A; Grit I; Drelon M; Duhamel A; Cabe N; Vabret F; Guillin O; Baguet A; Masquelier C; Dervaux A; Deheul S; Bordet R; Carton L; Cottencin O; Jardri R; Gautier S
Expert Opin Drug Saf; 2017 Feb; 16(2):125-132. PubMed ID: 27984918
[TBL] [Abstract][Full Text] [Related]
28. Baclofen: a new drug for the treatment of alcohol dependence.
Addolorato G; Leggio L; Agabio R; Colombo G; Gasbarrini G
Int J Clin Pract; 2006 Aug; 60(8):1003-8. PubMed ID: 16893442
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone response to the GABA-B agonist baclofen in 3-week abstinent alcoholics.
Ozsoy S; Esel E; Turan T; Kula M
Alcohol; 2007 Dec; 41(8):551-6. PubMed ID: 18047908
[TBL] [Abstract][Full Text] [Related]
30. Baclofen-Associated Onset of Central Sleep Apnea in Alcohol Use Disorder: A Case Report.
Perogamvros L; Pépin JL; Thorens G; Mégevand P; Claudel E; Espa F; Besson M; Cervena K; Janssens JP; Lador F
Respiration; 2015; 90(6):507-511. PubMed ID: 26390141
[TBL] [Abstract][Full Text] [Related]
31. Death of an alcohol-dependent patient following intentional drug intoxication: implication of baclofen?
Pape E; Roman E; Scala-Bertola J; Thivilier C; Javot L; Saint-Marcoux F; Jouzeau JY; Gambier N
Eur Addict Res; 2014; 20(6):300-4. PubMed ID: 25300747
[TBL] [Abstract][Full Text] [Related]
32. Control of esophageal distension-induced secondary peristalsis by the GABA(B) agonist baclofen in humans.
Chen CL; Liu TT; Yi CH
Neurogastroenterol Motil; 2011 Jul; 23(7):612-e250. PubMed ID: 21501336
[TBL] [Abstract][Full Text] [Related]
33. Intrathecal baclofen in cerebral palsy. A retrospective study of 25 wheelchair-assisted adults.
Tassëel Ponche S; Ferrapie AL; Chenet A; Menei P; Gambart G; Ménégalli Bogeli D; Perrouin Verbe B; Gay S; Richard I
Ann Phys Rehabil Med; 2010 Oct; 53(8):483-98. PubMed ID: 20829144
[TBL] [Abstract][Full Text] [Related]
34. Baclofen as relapse prevention in the treatment of gamma-hydroxybutyrate dependence: a case series.
Kamal RM; Loonen AJ; Dijkstra BA; De Jong CA
J Clin Psychopharmacol; 2015 Jun; 35(3):313-8. PubMed ID: 25900349
[TBL] [Abstract][Full Text] [Related]
35. Gambling disorder: a side effect of an off-label prescription of baclofen-literature review.
Guillou-Landreat M; Victorri Vigneau C; Gerardin M
BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28073872
[TBL] [Abstract][Full Text] [Related]
36. One year of baclofen in 100 patients with or without cirrhosis: a French real-life experience.
Barrault C; Lison H; Roudot-Thoraval F; Garioud A; Costentin C; Béhar V; Medmoun M; Pulwermacher G; Hagège H; Cadranel JF
Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1155-1160. PubMed ID: 28727631
[TBL] [Abstract][Full Text] [Related]
37. Role of the GABA(B) receptor system in alcoholism and stress: focus on clinical studies and treatment perspectives.
Addolorato G; Leggio L; Cardone S; Ferrulli A; Gasbarrini G
Alcohol; 2009 Nov; 43(7):559-63. PubMed ID: 19913201
[TBL] [Abstract][Full Text] [Related]
38. The GABA(B) antagonist CGP56433A attenuates the effect of baclofen on cocaine but not heroin self-administration in the rat.
Brebner K; Froestl W; Roberts DC
Psychopharmacology (Berl); 2002 Feb; 160(1):49-55. PubMed ID: 11862373
[TBL] [Abstract][Full Text] [Related]
39. Abstinence and 'low-risk' consumption 1 year after the initiation of high-dose baclofen: a retrospective study among 'high-risk' drinkers.
Rigal L; Alexandre-Dubroeucq C; de Beaurepaire R; Le Jeunne C; Jaury P
Alcohol Alcohol; 2012; 47(4):439-42. PubMed ID: 22434664
[TBL] [Abstract][Full Text] [Related]
40. Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial.
Morley KC; Baillie A; Fraser I; Furneaux-Bate A; Dore G; Roberts M; Abdalla A; Phung N; Haber PS
Br J Psychiatry; 2018 Jun; 212(6):362-369. PubMed ID: 29716670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
